Atrial Fibrillation Treatment Guidelines Development Committee: Korean Society of Arrhythmia Guidelines for the Use of Vitamin K-Independent Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation (2022)

In a pericardial fibrillation patient, vitamin - bitamine Kignin Kignid Kigni kp3h ngngulant (low - C.O.C.) is preferred and used more for preventing stroke than vitamin K-K anti-K. The number of NOACs is now being used in the country, and there are davigatrans that directly suppress the pecixaban, escalaban and ribarock savane and direct trombin. The NOAC has a good safety contrast and is a predictable antiresponsive effect that does not require regular anti-resistance monitoring. For proper use of the NOAC, the A.V.C. has developed a new standard of consults for the anti-A.Cs and care measures. 1) Target patient's capacity and maintenance of the NOAC; (2) care to keep track of the beginning and maintenance for medication; (3) interaction between drug and drug abuse; (4) interaction with the drug and the blood level; 5 of the blood volume; 6 of the bleeding during the treatment; 7 of emergency surgery; (8) instructions on how to take pre-op/ surgical or post-op. (8) coronary disease; (9) CAD; 10) acute stroke; 11 of certain disorders; 12 of the current adjustment in the range of the device.

Korean title: 대한부정맥학회 심방세동 환자에서 비타민K 비의존성 경구용 항응고제(NOAC) 사용 지침(2022)

Korean author: 심방세동 진료 지침 개발위원회

Korean publisher: 전남대학교출판문화원

ISBN-13: 9788968498817